mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.24 |
3e-11 |
mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.24 |
7e-11 |
mRNA |
Sunitinib |
GDSC1000 |
pan-cancer |
AAC |
0.37 |
2e-10 |
mRNA |
TKI258 |
CCLE |
pan-cancer |
AAC |
0.32 |
2e-09 |
mRNA |
Sunitinib |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
2e-09 |
mRNA |
Sorafenib |
GDSC1000 |
pan-cancer |
AAC |
0.36 |
4e-09 |
mRNA |
BX-912 |
GDSC1000 |
pan-cancer |
AAC |
0.21 |
8e-09 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
1e-08 |
mRNA |
PD318088 |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
2e-08 |
mRNA |
GSK-650394 |
GDSC1000 |
pan-cancer |
AAC |
0.24 |
2e-08 |